soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 reduced the risk of clinically important kidney and death from (CV) causes in patients with type 2 diabetes (T2D) and CKD ca. #ERA24 🇸🇪 #Nephpearls https://www.nejm .org/doi/full/10.1056/NEJMoa2403347 soul trial oral semaglutide cardiovascular

Many transgender persons have reported significant levels of depression, anxiety, social isolation, and even suicidal ideation

Mix 4 g of powder in 200 ml of water (approximately 2 scoops), 30 minutes before physical activity.

(2015) GLP-1/glucagon co-agonist REE data, which remains the mechanistic anchor for every triagonist programme that followed [unverified]

These results indicated that the administration of 2APB effectively inhibited the transmission of oxidative stress molecules by hepatocyte GJs and impacted oxidative stress in the liver

Less than half do it in a way that protects their physiology

TB-500 at a Glance BPC-157 and TB-500 are both commonly discussed as recovery peptides, but they are not interchangeable